Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral Infections
- 5 January 2011
- journal article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 26 (2) , 161-168
Abstract
The present study evaluated the plausible role of circulating biomarkers in immune pathogenesis of chronic hepatitis considered a priority in clinical hepatology. Total viral load of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) patients was quantified and correlation studies were performed with circulating levels of Th1/Th2 cytokines; C reactive protein and circulating nucleosomes; glutathione reductase (GR) and superoxide dismutase. To our knowledge, the study is first among its kind that validates strong positive correlation of viral load with IL-4, IL-6, GR in HBV and IL-6, IL-10, GR in HCV infections. Although, multi-centric studies including large cohorts are required for translating our findings to clinical practice, however, role of these biomarkers with potential diagnostic or prognostic significance might be helpful in clinical assessment of high-risk individuals, thereby, designing interventional strategies, towards development of personalized medicare. The results of our study also offer valuable insights of immune signaling mediators engaged in development of hepatocellular carcinoma.Keywords
This publication has 42 references indexed in Scilit:
- Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytesVirus Research, 2010
- Mitochondrial oxidative stress elicits chromosomal instability after exposure to isocyanates in human kidney epithelial cellsFree Radical Research, 2009
- Epidemiology and Survival of Hepatocellular Carcinoma in Turkey: Outcome of Multicenter StudyJapanese Journal of Clinical Oncology, 2008
- Serum C‐reactive protein levels predict survival in hepatocellular carcinomaLiver International, 2007
- Predictive Power of Biomarkers of Oxidative Stress and Inflammation in Patients with Hepatitis C Virus-Associated Hepatocellular CarcinomaAnnals of Surgical Oncology, 2006
- C-Reactive Protein and Cerebral Small-Vessel DiseaseCirculation, 2005
- Clinical biomarkers in drug discovery and developmentNature Reviews Drug Discovery, 2003
- A new hypothesis of pathogenetic mechanism of viral hepatitis B and CMedical Hypotheses, 2001
- Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitisJournal of Viral Hepatitis, 1997
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993